Evaluation of the Efficacy of Dasatinib, a SRC/Abl Inhibitor, in Colorectal Cancer Cell Lines and Explant Mouse Model
PLoS ONE - United States
doi 10.1371/journal.pone.0187173
Full Text
Open PDFAbstract
Available in full text
Categories
Date
November 1, 2017
Authors
Publisher
Public Library of Science (PLoS)